FDA Commissioner Marty Makary has revealed a new priority review voucher programme for new medicines deemed to be of national ...

Revenues increased 220% to $3.7 million, compared with $1.2 million for the fiscal year ended March 31, 2024 Expect to report revenue of at least $1.7 million for quarter ending June 30, 2025, and int ...